Skip to main content

Rheumatic Diseases (Compound E)

Volume 467: debated on Tuesday 12 July 1949

The text on this page has been created from Hansard archive content, it may contain typographical errors.

32.

asked the Lord President of the Council in view of the satisfactory evidence as to the efficacy of compound E in the treatment of rheumatic diseases, what steps are being taken through the Medical Research Council or other bodies to ensure the production of this drug on a large scale at the earliest possible date.

Research aimed at finding effective new substances akin to compound E is in active progress under the Medical Research Council, but I am advised that all these compounds are exceptionally difficult to make and that early success is not to be expected. Large-scale production of compound E itself is a matter for commercial laboratories rather than the Council, but here again the difficulty of synthesis must hamper speed, and I understand that the American manufacturers of the compound that intimated that it is unlikely to be generally available for use by doctors even in the United States for several years at least.